RenovoRX, Inc. (RNXT) Press Releases https://ir.renovorx.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/renovorx/files/theme/images/logo-sm.png RenovoRX, Inc. Logo Equisolve Investor Relations Suite <![CDATA[RenovoRx Regains Compliance with Nasdaq Minimum Bid Price Requirement]]> https://ir.renovorx.com/news-events/press-releases/detail/173/renovorx-regains-compliance-with-nasdaq-minimum-bid-price Fri, 21 Aug 26 08:30:00 -0400 https://ir.renovorx.com/news-events/press-releases/detail/173/renovorx-regains-compliance-with-nasdaq-minimum-bid-price <![CDATA[RenovoRx Receives Notice of Allowance for New U.S. Patent Covering RenovoCath®, an Advanced Dual-Occlusion Catheter, for Targeted Therapeutic Drug-Delivery for Cancer Treatment]]> https://ir.renovorx.com/news-events/press-releases/detail/172/renovorx-receives-notice-of-allowance-for-new-u-s-patent Thu, 20 Aug 26 08:30:00 -0400 https://ir.renovorx.com/news-events/press-releases/detail/172/renovorx-receives-notice-of-allowance-for-new-u-s-patent <![CDATA[RenovoRx Reports Record Second Quarter 2026 Results, Driven by Accelerating Commercial Adoption and 61% Sequential Quarterly Revenue Growth]]> https://ir.renovorx.com/news-events/press-releases/detail/171/renovorx-reports-record-second-quarter-2026-results-driven Wed, 12 Aug 26 16:05:00 -0400 https://ir.renovorx.com/news-events/press-releases/detail/171/renovorx-reports-record-second-quarter-2026-results-driven <![CDATA[RenovoRx Achieves Major Milestone with Full Enrollment in Phase III TIGeR-PaC Trial for Locally Advanced Pancreatic Cancer]]> https://ir.renovorx.com/news-events/press-releases/detail/170/renovorx-achieves-major-milestone-with-full-enrollment-in Tue, 11 Aug 26 08:30:00 -0400 https://ir.renovorx.com/news-events/press-releases/detail/170/renovorx-achieves-major-milestone-with-full-enrollment-in <![CDATA[RenovoRx Announces First Commercial Clinical Use of RenovoCath® in Sarcoma Patient Treatment, Marking Expansion of Targeted Drug-Delivery Device to Other Solid Tumors]]> https://ir.renovorx.com/news-events/press-releases/detail/169/renovorx-announces-first-commercial-clinical-use-of Thu, 06 Aug 26 08:30:00 -0400 https://ir.renovorx.com/news-events/press-releases/detail/169/renovorx-announces-first-commercial-clinical-use-of <![CDATA[RenovoRx to Highlight TAMP™ Platform at JonesTrading Virtual Key Opinion Leader Webinar on the Evolving Pancreatic Cancer Landscape, August 13th]]> https://ir.renovorx.com/news-events/press-releases/detail/168/renovorx-to-highlight-tamp-platform-at-jonestrading Tue, 04 Aug 26 08:30:00 -0400 https://ir.renovorx.com/news-events/press-releases/detail/168/renovorx-to-highlight-tamp-platform-at-jonestrading <![CDATA[RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET]]> https://ir.renovorx.com/news-events/press-releases/detail/167/renovorx-to-host-second-quarter-2026-financial-results-and Wed, 29 Jul 26 08:30:00 -0400 https://ir.renovorx.com/news-events/press-releases/detail/167/renovorx-to-host-second-quarter-2026-financial-results-and <![CDATA[RenovoRx Highlights Peer-Reviewed Publication Supporting Intra-Arterial Gemcitabine Delivery Via TAMP™ in Locally Advanced Pancreatic Cancer]]> https://ir.renovorx.com/news-events/press-releases/detail/166/renovorx-highlights-peer-reviewed-publication-supporting Thu, 11 Jun 26 08:30:00 -0400 https://ir.renovorx.com/news-events/press-releases/detail/166/renovorx-highlights-peer-reviewed-publication-supporting <![CDATA[RenovoRx CEO, Shaun Bagai, to Present at the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 on June 23rd]]> https://ir.renovorx.com/news-events/press-releases/detail/165/renovorx-ceo-shaun-bagai-to-present-at-the-iaccess-alpha Thu, 04 Jun 26 08:30:00 -0400 https://ir.renovorx.com/news-events/press-releases/detail/165/renovorx-ceo-shaun-bagai-to-present-at-the-iaccess-alpha <![CDATA[RenovoRx Announces FDA Orphan Drug Designation Granted: Oxaliplatin for the Treatment of Pancreatic Cancer]]> https://ir.renovorx.com/news-events/press-releases/detail/164/renovorx-announces-fda-orphan-drug-designation-granted Thu, 28 May 26 08:30:00 -0400 https://ir.renovorx.com/news-events/press-releases/detail/164/renovorx-announces-fda-orphan-drug-designation-granted